Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age

Marta Velasco Rodríguez-Belvís1, Javier Francisco Viada Bris1, Carmen Plata Fernández2

  • 1Gastroenterology and Nutrition Department, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.

Insights

Pediatric fecal calprotectin (FC) levels are higher in infants and decrease with age. This study established normal FC ranges in healthy children, finding age is the primary factor influencing levels.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Biochemistry

Background:

  • Establishing reliable pediatric reference ranges for fecal calprotectin (FC) is crucial due to wide age-related variability.
  • Factors such as anthropometrics and feeding type may influence FC levels in children.

Purpose of the Study:

  • To establish normal fecal calprotectin (FC) levels in healthy children, stratified by age.
  • To investigate the influence of sex, gestational age, birth weight, delivery type, feeding type, and anthropometric data on pediatric FC values.

Main Methods:

  • A multicenter, cross-sectional, observational study included 395 healthy children under 18 years.
  • Exclusion criteria focused on conditions and factors that could affect FC levels, such as immunodeficiency, gastrointestinal disease, and medication use.

Main Results:

  • A significant negative correlation was observed between age and FC levels (Spearman's rho = -0.603, P<0.01).
  • The median FC level was 77.0 mcg/g (IQR 246).
  • No significant influence was found for sex, gestational age, birth weight, delivery type, feeding type, or anthropometric data on FC levels.

Conclusions:

  • Normal FC values in healthy children are higher than adult levels and decrease with age.
  • Current upper limits for FC in pediatric patients may need age-specific reconsideration.
  • Further research is needed to understand FC variations during infancy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
617
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175